Novarex
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Novarex makes health-supplement products, vitamins, functional foods, and similar consumer wellness items, supplied to retailers and brands that reach everyday shoppers.
The company is listed on KOSDAQ, South Korea's tech and small-cap exchange. The filing's table of contents indicates the business spans both a parent entity and consolidated subsidiaries, suggesting Novarex operates across more than one legal entity under a single reporting group.
Summary is AI-generated and may contain errors · figures from DART filings
Novarex in five facts
What does Novarex do?
Novarex makes health-supplement products, vitamins, functional foods, and similar consumer wellness items, supplied to retailers and brands that reach everyday shoppers.
Where is Novarex listed and in which sector?
Novarex (Korean name: 노바렉스) trades under KRX code 194700 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Novarex?
Its market capitalisation was US$134.6M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Novarex's latest annual revenue and operating profit?
For fiscal year 2025, Novarex reported revenue of US$305.1M, operating profit of US$32.5M and net income of US$27.1M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 35.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on large shareholdings (5% rule) (standard)Oct 20
- Cash/in-kind dividend decision
Novarex declared a cash dividend of US$0.27 per share, equal to about 2.8% of the recent share price.
Dividend · Mar 12 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Novarex reported consolidated results for FY2025: revenue of US$279M (+35.8% year on year), operating profit of US$29.7M (+85.6% year on year) and net income of US$24.8M (+50.9% year on year).
Earnings · Feb 2